Medical Devices That Feels Human 2024
Why Crispidea Report
This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.
Industry Analysis
Devices used for cardiovascular disease diagnosis, monitoring and treatment comprise the largest product category with heart conditions rising globally, demand for ECG systems, pacemakers, stents and related technologies continues to grow significantly.
Emerging Trends
Medtech funding and investment momentum slowed down in 2022-23 relative to the 2021 peak, but market outlook remains positive overall driven by aging populations and rising disease burden. While MedTech funding hit a high in 2021, investment activity has moderated recently due to economic instability and investor cautiousness.
CrispIdea Outlook
The medical device industry plays a pivotal role in transforming healthcare through ongoing technological innovation. Valued at $479bn in 2023, the market is forecast to expand steadily to over $800bn by 2030. Key factors propelling this robust trajectory include the rising prevalence of chronic diseases, shift towards home healthcare services and remote patient monitoring, rapid pace of product innovation, increased healthcare expenditure and supportive regulatory ecosystems.
Table of Content
Executive Summary
– Market Overview
– Regional Outlook
– Key Players
– Factors Driving Growth
– Top Trends for 2024 and Beyond
– Stock and Index Performance
– Outlook
– Conclusion
• Key Players
– ABT
– Agilent
– BDX
– BSX
– MDT
– BAX
– SYK
• CrispIdea Coverage
– ABT
– Agilent
– BDX
– BSX
– MDT
– BAX
– SYK
Disclaimer
This report was produced by a member company of the Crispidea. This report is for the use of intended recipients only and may not be reproduced (in whole or in part) or delivered or transmitted to any other person without our prior written consent. By accepting this report, the recipient agrees to be bound by the terms and limitations set out herein.
